References
Wadhwa R, Song S, Lee JS, Yao Y, Wei Q, Ajani JA. Gastric cancer: molecular and clinical dimensions. Nat Rev Clin Oncol. 2013;10:643–55.
Kanda M, Shimizu D, Tanaka H, et al. Significance of SYT8 for the detection, prediction, and treatment of peritoneal metastasis from gastric cancer. Ann Surg. 2018;267:495–503.
Kanda M, Shimizu D, Tanaka H, et al. Synaptotagmin XIII expression and peritoneal metastasis in gastric cancer. Br J Surg. 2018;105:1349–58.
Sawaki K, Kanda M, Miwa T, et al. Troponin I2 as a specific biomarker for prediction of peritoneal metastasis in gastric cancer. Ann Surg Oncol. 2018;25:2083–90.
Sawaki K, Kanda M, Kodera Y. Review of recent efforts to discover biomarkers for early detection, monitoring, prognosis, and prediction of treatment responses of patients with gastric cancer. Expert Rev Gastroenterol Hepatol. 2018;12:657–70.
Author information
Authors and Affiliations
Corresponding author
Additional information
ASO Author Reflections offer a brief invited commentary on the article, “Troponin I2 as a Specific Biomarker for Detection and Prediction of Peritoneal Metastasis in Gastric Cancer”. Ann Surg Oncol. 2018;25:2083–2090.
Rights and permissions
About this article
Cite this article
Sawaki, K., Kanda, M. ASO Author Reflections: Troponin I2—A Specific Biomarker for Detection and Prediction of Peritoneal Metastasis in Gastric Cancer. Ann Surg Oncol 25 (Suppl 3), 709–710 (2018). https://doi.org/10.1245/s10434-018-6801-2
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-018-6801-2